Hormonal therapy is a mainstay in the clinical management of patients with breast tumors that express estrogen receptor (ER). The antitumor efficacy of these endocrine treatments depends on tight regulation of breast tumor cell growth by estrogens and growth factors. However, as these cancers
No takes yet. Share an insight, caveat, or question.
Pietras et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: